Pauline Corbaux

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 16

Top Topics

Early Breast Cancer

Liver Metastases

Neoadjuvant Chemotherapy

Top Venues

Biomarkers in medicine

International journal of clinical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Pauline Corbaux, Olivier Colomban, Aurore Carrot, Benoit You
KELIM score predicts outcome in patients with platinum-resistant/refractory recurrent ovarian cancer. Biomarkers in medicine (2024)
Pauline Corbaux, Olivier Colomban, Aurore Carrot, Benoit You
KELIM score predicts outcome in patients with platinum-resistant/refractory recurrent ovarian cancer. Biomarkers in medicine 18 (10-12) (2024)
Pauline Corbaux, Olivier Colomban, Aurore Carrot, Benoit You
KELIM score predicts outcome in patients with platinum-resistant/refractory recurrent ovarian cancer. Biomarkers in medicine 18 (10-12) (2024)
Pauline Corbaux, Gilles Freyer, Olivier Glehen, Benoit You, Naoual Bakrin, Audrey Gelot, David Dayde, Christophe Sajous, Max Piffoux, Julien Péron, Gaelle Lescuyer, Léa Payen, Vahan Kepenekian
Intraperitoneal Nivolumab After Debulking Surgery and Hyperthermic Intraperitoneal Chemotherapy in Advanced Ovarian Cancer: A Phase I Study with Expansion Cohort. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Pauline Corbaux, Gilles Freyer, Olivier Glehen, Benoit You, Naoual Bakrin, Audrey Gelot, David Dayde, Christophe Sajous, Max Piffoux, Julien Péron, Gaelle Lescuyer, Léa Payen, Vahan Kepenekian
Intraperitoneal Nivolumab after Debulking Surgery and Hyperthermic Intraperitoneal Chemotherapy in Advanced Ovarian Cancer: A Phase I Study with Expansion Cohort. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (16) (2024)
Pauline Corbaux, Olivier Colomban, Aurore Carrot, Benoit You
KELIM score predicts outcome in patients with platinum-resistant/refractory recurrent ovarian cancer. Biomarkers in medicine 18 (10-12) (2024)
Pauline Corbaux, Catherine Terret, Claire Cropet, Sylvie Chabaud, Chiara Russo, Christelle Faure, Olivier Tredan, Thomas Bachelot, Pierre Etienne Heudel
Association of chemotherapy and comorbidities with overall survival in elderly patients with early breast cancer: a French population-based propensity score-matched analysis. International journal of clinical oncology 28 (3) (2023)
Pauline Corbaux, Catherine Terret, Claire Cropet, Sylvie Chabaud, Chiara Russo, Christelle Faure, Olivier Tredan, Thomas Bachelot, Pierre Etienne Heudel
Association of chemotherapy and comorbidities with overall survival in elderly patients with early breast cancer: a French population-based propensity score-matched analysis. International journal of clinical oncology 28 (3) (2023)
Pauline Corbaux, Catherine Terret, Claire Cropet, Sylvie Chabaud, Chiara Russo, Christelle Faure, Olivier Tredan, Thomas Bachelot, Pierre Etienne Heudel
Association of chemotherapy and comorbidities with overall survival in elderly patients with early breast cancer: a French population-based propensity score-matched analysis. International journal of clinical oncology (2023)
Pauline Corbaux, Catherine Terret, Claire Cropet, Sylvie Chabaud, Chiara Russo, Christelle Faure, Olivier Tredan, Thomas Bachelot, Pierre Etienne Heudel
Association of chemotherapy and comorbidities with overall survival in elderly patients with early breast cancer: a French population-based propensity score-matched analysis. International journal of clinical oncology 28 (3) (2023)
Madeleine Maugeais, Julien Péron, Stéphane Dalle, Amélie Boespflug, Michaël Duruissaux, Pauline Corbaux, Thibault Reverdy, Gulsum Sahin, Aurélie Rabier, Jonathan Lopez, Nathalie Freymond, Denis Maillet
Impact of Liver Metastases and Number of Metastatic Sites on Immune-Checkpoint Inhibitors Efficacy in Patients with Different Solid Tumors: A Retrospective Study. Biomedicines 11 (1) (2022)
Madeleine Maugeais, Julien Péron, Stéphane Dalle, Amélie Boespflug, Michaël Duruissaux, Pauline Corbaux, Thibault Reverdy, Gulsum Sahin, Aurélie Rabier, Jonathan Lopez, Nathalie Freymond, Denis Maillet
Impact of Liver Metastases and Number of Metastatic Sites on Immune-Checkpoint Inhibitors Efficacy in Patients with Different Solid Tumors: A Retrospective Study. Biomedicines 11 (1) (2022)
Madeleine Maugeais, Julien Péron, Stéphane Dalle, Amélie Boespflug, Michaël Duruissaux, Pauline Corbaux, Thibault Reverdy, Gulsum Sahin, Aurélie Rabier, Jonathan Lopez, Nathalie Freymond, Denis Maillet
Impact of Liver Metastases and Number of Metastatic Sites on Immune-Checkpoint Inhibitors Efficacy in Patients with Different Solid Tumors: A Retrospective Study. Biomedicines 11 (1) (2022)
Ambroise Lauby, Olivier Colomban, Pauline Corbaux, Julien Péron, Lilian Van Wagensveld, Witold Gertych, Naoual Bakrin, Pierre Descargues, Jonathan Lopez, Vahan Kepenekian, Olivier Glehen, Charles Andre Philip, Mojgan Devouassoux-Shisheboran, Michel Tod, Gilles Freyer, Benoit You
The Increasing Prognostic and Predictive Roles of the Tumor Primary Chemosensitivity Assessed by CA-125 Elimination Rate Constant K (KELIM) in Ovarian Cancer: A Narrative Review. Cancers 14 (1) (2021)
Pauline Corbaux, Audrey Lardy-Cleaud, Marie Alexandre, Maxime Fontanilles, Christelle Lévy, Alessandro Adriano Viansone, Audrey Mailliez, Marc Debled, Anthony Goncalves, Fanny Le Du, Florence Lerebours, Jean-Marc Ferrero, Jean-Christophe Eymard, Marie-Ange Mouret-Reynier, Thierry Petit, Jean-Sébastien Frenel, Florence Dalenc, Coralie Courtinard, Marie Chaix, Thomas Bachelot
Progression-free survival on endocrine therapy, before or after chemotherapy, in hormone receptor-positive HER2-negative metastatic breast cancer. Breast cancer research and treatment (2021)
Charline Lafayolle de la Bruyère, Pierre-Jean Souquet, Stéphane Dalle, Pauline Corbaux, Amélie Boespflug, Michaël Duruisseaux, Lize Kiakouama-Maleka, Thibault Reverdy, Madeleine Maugeais, Gulsum Sahin, Denis Maillet, Julien Péron
Investigating the Impact of Immune-Related Adverse Events, Glucocorticoid Use and Immunotherapy Interruption on Long-Term Survival Outcomes. Cancers 13 (10) (2021)